Are SSRIs Safe During Pregnancy? What the Research Actually Says.
If you are pregnant or thinking about it and you take an SSRI, you have probably felt the question land in your chest. Should I stop? Will this hurt my baby? Am I a bad mother for needing medication at all?
You are not alone in asking, and you are not wrong to want clear answers. SSRIs in pregnancy is one of the most studied questions in all of reproductive medicine. The headlines do not always reflect that, but the science is deep, and it is more reassuring than you may have been led to believe.
Here is a calm, evidence-based look at what we actually know.
First, the question underneath the question
When patients ask whether they can stay on their antidepressant, they are usually weighing one risk. The honest answer is that there are two.
There is the question of medication exposure. And there is the question of what happens when depression or anxiety goes untreated during pregnancy. Both matter. A good decision looks at both, together, rather than treating "no medication" as automatically the safer choice.
Untreated depression in pregnancy is not a neutral background state. It is linked to poorer prenatal care, preterm birth, low birth weight, difficulty bonding after delivery, and a higher risk of postpartum depression. For some women, stopping a medication that was holding them steady is the very thing that puts a pregnancy at risk.
That is the frame reproductive psychiatry works from. Not "is this drug perfectly risk free," because nothing in pregnancy is, but "what is the safest path for this particular person and this particular pregnancy."
What the research shows about SSRIs in pregnancy
Let's walk through the concerns patients raise most often.
Birth defects and heart malformations
This is usually the first worry. Early studies suggested a possible link between first-trimester SSRI use and heart defects, especially with paroxetine. Those findings drove a lot of fear.
But larger, better-designed studies told a different story. A landmark analysis of nearly one million pregnancies found that once researchers accounted for the depression itself and other confounding factors, there was no meaningful increase in cardiac malformations from antidepressant use in the first trimester (Huybrechts et al., 2014). In other words, much of the early signal came from the illness being treated, not the treatment.
The current consensus is that most SSRIs do not meaningfully raise the risk of major birth defects.
Autism and ADHD
You may have seen claims linking antidepressants in pregnancy to autism or ADHD. This concern resurfaces often, and it deserves a careful answer.
The strongest studies use sibling comparisons, which help separate the effect of the medication from the genetics and environment a family shares. When researchers did this, the apparent link to autism and ADHD largely disappeared (Sujan et al., 2017; Brown et al., 2017). What remained pointed back toward the underlying maternal mental health condition and family factors, not the SSRI.
No serious researcher claims the question is fully closed. But the best available evidence does not support the idea that SSRIs cause autism.
Risks around delivery
Two real, well-documented effects are worth naming honestly.
The first is neonatal adaptation syndrome. Some babies exposed to SSRIs late in pregnancy are briefly jittery, fussy, or have trouble feeding in the first days of life. It is usually mild and resolves on its own.
The second is persistent pulmonary hypertension of the newborn, or PPHN, a serious breathing condition. Research has found a possible small increase in risk with late-pregnancy SSRI use, but the absolute risk stays low, and the effect is more modest than older studies suggested (Huybrechts et al., 2015). PPHN affects roughly one to two infants per thousand births overall.
These are reasons to plan your delivery thoughtfully, not reasons to assume the worst.
So why all the recent headlines?
In July 2025, an FDA expert panel met to discuss SSRIs in pregnancy, and the coverage that followed left a lot of people frightened. If you saw those headlines and panicked, that reaction makes sense.
Here is the context that often got left out. Major medical organizations, including the American College of Obstetricians and Gynecologists, the Society for Maternal-Fetal Medicine, and the American Psychiatric Association, publicly responded that the panel was unbalanced and downplayed the well-documented harms of untreated perinatal depression. ACOG's guidance continues to support access to SSRIs in pregnancy and recommends against stopping mental health treatment based on pregnancy status alone.
A single dramatic meeting does not overturn decades of careful research. The standard of care has not changed: these decisions should be individualized, made with a clinician who knows the full picture.
What this means for you
A few principles guide good care here.
Do not stop your medication abruptly on your own. Stopping suddenly can trigger withdrawal and a return of symptoms, sometimes worse than before. If you are reconsidering your medication, that is a conversation to have with a psychiatrist, ideally before you conceive.
Not every SSRI is the same. Some have a stronger safety record in pregnancy than others. Sometimes the right move is to stay the course, sometimes to switch, and sometimes the safest plan really is to continue exactly what is working.
Therapy is part of the picture too. For mild to moderate symptoms, approaches like cognitive behavioral therapy can be a meaningful piece of the plan, alone or alongside medication. Treatment is not all or nothing.
Your history matters. A first episode of mild anxiety calls for a different conversation than a history of severe depression that has relapsed every time medication stopped.
This is exactly the kind of nuanced decision that reproductive psychiatry exists for. It is not about pushing pills or withholding them. It is about helping you weigh real risks against real benefits, with your values at the center.
You deserve a real conversation, not a scary headline
The decision about SSRIs in pregnancy is yours to make, but you should not have to make it alone or based on fear. At our practice in Austin, we specialize in perinatal mental health and the full reproductive lifespan, and these conversations are a core part of what we do every day.
Whether you are planning a pregnancy, newly expecting, or navigating depression or anxiety while pregnant, there is a thoughtful path forward. Caring for yourself is part of caring for your baby. They are not in competition.
Ready to take the next step? Estela Mental Health is located in Austin and accepts several major insurance plans including Aetna, Blue Cross Blue Shield, Cigna/Evernorth, Optum, and United Healthcare. Book an appointment today and let's figure this out together.
Related: Reproductive Psychiatry · Perinatal Mental Health · Women's Mental Health · Depression · Anxiety
References
Brown, H. K., Ray, J. G., Wilton, A. S., Lunsky, Y., Gomes, T., & Vigod, S. N. (2017). Association between serotonergic antidepressant use during pregnancy and autism spectrum disorder in children. JAMA, 317(15), 1544–1552.
Huybrechts, K. F., Palmsten, K., Avorn, J., Cohen, L. S., Holmes, L. B., Franklin, J. M., Mogun, H., Levin, R., Kowal, M., Setoguchi, S., & Hernández-Díaz, S. (2014). Antidepressant use in pregnancy and the risk of cardiac defects. New England Journal of Medicine, 370(25), 2397–2407.
Huybrechts, K. F., Bateman, B. T., Palmsten, K., Desai, R. J., Patorno, E., Gopalakrishnan, C., Levin, R., Mogun, H., & Hernández-Díaz, S. (2015). Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. JAMA, 313(21), 2142–2151.
Sujan, A. C., Rickert, M. E., Öberg, A. S., Quinn, P. D., Hernández-Díaz, S., Almqvist, C., Lichtenstein, P., Larsson, H., & D'Onofrio, B. M. (2017). Associations of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit/hyperactivity disorder in offspring. JAMA, 317(15), 1553–1562.
This post is for educational purposes only and is not a substitute for individualized medical advice. Decisions about medication during pregnancy should always be made in consultation with your own physician or psychiatrist.
